GLAND PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,764 INR | +0.14% |
|
+3.37% | -8.29% |
| May. 07 | Gland Pharma Gets US FDA's Approval for Generic ALS Drug | MT |
| May. 07 | Gland Pharma Gets US FDA's Approval for Generic Stem Cell Mobilizer Injection | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 3.48B | ||||||
| 682B | ||||||
| 586B | ||||||
| 364B | ||||||
| 327B | ||||||
| 285B |
